LONN.SW vs. ROVI.MC
Compare and contrast key facts about Lonza Group AG (LONN.SW) and Laboratorios Farmaceuticos ROVI (ROVI.MC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LONN.SW or ROVI.MC.
Performance
LONN.SW vs. ROVI.MC - Performance Comparison
Returns By Period
In the year-to-date period, LONN.SW achieves a 44.67% return, which is significantly higher than ROVI.MC's 4.41% return. Over the past 10 years, LONN.SW has underperformed ROVI.MC with an annualized return of 18.85%, while ROVI.MC has yielded a comparatively higher 22.26% annualized return.
LONN.SW
44.67%
-8.01%
-4.04%
44.14%
9.31%
18.85%
ROVI.MC
4.41%
-18.27%
-28.41%
21.58%
21.34%
22.26%
Fundamentals
| LONN.SW | ROVI.MC | |
|---|---|---|
| Market Cap | CHF 40.30B | €3.34B |
| EPS | CHF 7.97 | €3.18 |
| PE Ratio | 70.11 | 20.55 |
| Total Revenue (TTM) | CHF 6.70B | €563.97M |
| Gross Profit (TTM) | CHF 1.96B | €334.55M |
| EBITDA (TTM) | CHF 1.85B | €143.29M |
Key characteristics
| LONN.SW | ROVI.MC | |
|---|---|---|
| Sharpe Ratio | 1.50 | 0.64 |
| Sortino Ratio | 2.43 | 0.95 |
| Omega Ratio | 1.30 | 1.15 |
| Calmar Ratio | 0.77 | 0.62 |
| Martin Ratio | 6.62 | 1.88 |
| Ulcer Index | 6.77% | 10.36% |
| Daily Std Dev | 29.94% | 30.41% |
| Max Drawdown | -76.67% | -66.94% |
| Current Drawdown | -34.03% | -31.30% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between LONN.SW and ROVI.MC is 0.25, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
LONN.SW vs. ROVI.MC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Lonza Group AG (LONN.SW) and Laboratorios Farmaceuticos ROVI (ROVI.MC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LONN.SW vs. ROVI.MC - Dividend Comparison
LONN.SW's dividend yield for the trailing twelve months is around 0.79%, less than ROVI.MC's 1.44% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LONN.SW Lonza Group AG | 0.79% | 0.99% | 0.66% | 0.39% | 0.48% | 0.78% | 1.08% | 1.04% | 1.42% | 1.53% | 1.92% | 2.54% |
ROVI.MC Laboratorios Farmaceuticos ROVI | 1.44% | 1.74% | 2.15% | 0.42% | 0.37% | 0.26% | 0.56% | 0.95% | 0.91% | 0.94% | 1.24% | 1.08% |
Drawdowns
LONN.SW vs. ROVI.MC - Drawdown Comparison
The maximum LONN.SW drawdown since its inception was -76.67%, which is greater than ROVI.MC's maximum drawdown of -66.94%. Use the drawdown chart below to compare losses from any high point for LONN.SW and ROVI.MC. For additional features, visit the drawdowns tool.
Volatility
LONN.SW vs. ROVI.MC - Volatility Comparison
The current volatility for Lonza Group AG (LONN.SW) is 10.35%, while Laboratorios Farmaceuticos ROVI (ROVI.MC) has a volatility of 16.08%. This indicates that LONN.SW experiences smaller price fluctuations and is considered to be less risky than ROVI.MC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
LONN.SW vs. ROVI.MC - Financials Comparison
This section allows you to compare key financial metrics between Lonza Group AG and Laboratorios Farmaceuticos ROVI. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities